Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Genitourinary 5Thoracic 2Breast 2Tumor-Agnostic 1Sarcoma 1Plasma cell 1Other 1Lymphoid 1Gastrointestinal 1Dermatologic 1

Conditions

Lung Neoplasms 2

Interventions

Blood Specimen Collection 53Surveys and Questionnaires 30Drug Therapy 27Immunotherapy 25Surgical Procedures, Operative 22Carboplatin 22Nivolumab 21Immune Checkpoint Inhibitors 20pembrolizumab 18osimertinib 18atezolizumab 17Observation 17Radiotherapy 16Bevacizumab 15Cisplatin 14Afatinib 14Specimen Handling 13Gene Expression Profiling 13Erlotinib Hydrochloride 13lorlatinib 12Pemetrexed 12Magnetic Resonance Spectroscopy 11Ipilimumab 11Immunohistochemistry 11Biopsy 11durvalumab 10alectinib 10Paclitaxel 10Bronchoscopy 10Tomography, X-Ray Computed 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Urine Specimen Collection × Thoracic × Clear all
NCT00898313 2026-04-27

Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer

Vanderbilt-Ingram Cancer Center

Recruiting
4,000 enrolled
Thoracic

Lung Neoplasms

NCT03047616 2021-04-19

A Pilot Study to Develop Predictive Biomarkers for the Response to Immunotherapy in Lung Cancer

Abramson Cancer Center at Penn Medicine

Completed
88 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡